Functional analysis of killer Ig-like receptor-expressing cytomegalovirus-specific CD8+ T cells

Journal of Immunology

Volumn 182, Issue 1, 2009, Pages 92-101

  Van Der Veken, Lars T ^a   Campelo, Maria Diez ^a   Van Der Hoorn, Menno A W G ^a   Hagedoorn, Renate S ^a   Van Egmond, H M Esther ^a   Van Bergen, Jeroen ^a   Willemze, Roel ^a   Falkenburg, J H Frederik ^a   Heemskerk, Mirjam H M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HLA A1 ANTIGEN; HLA A2 ANTIGEN; HLA B7 ANTIGEN; HLA B8 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; EPITOPE; LYMPHOCYTE ANTIGEN RECEPTOR;

ARTICLE; CD8+ T LYMPHOCYTE; CELL FUNCTION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOLYSIS; CYTOMEGALOVIRUS; CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; VIRUS ACTIVATION; BIOSYNTHESIS; CELL CLONE; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC TRANSDUCTION; GENETICS; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; RECURRENT DISEASE; RETROVIRUS; STEM CELL TRANSPLANTATION; T LYMPHOCYTE SUBPOPULATION; VIROLOGY;

CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CLONE CELLS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOTOXICITY, IMMUNOLOGIC; EPITOPES, T-LYMPHOCYTE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; RECEPTORS, ANTIGEN, T-CELL; RECEPTORS, KIR; RECURRENCE; RETROVIRIDAE; STEM CELL TRANSPLANTATION; T-LYMPHOCYTE SUBSETS; TRANSDUCTION, GENETIC;

EID: 59849127315     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.182.1.92     Document Type: Article

References (42)

1. Long, E. O. 1999. Regulation of immune responses through inhibitory receptors. Annu. Rev. Immunol. 17: 875-904.
2. Bendelac, A., M. N. Rivera, S. H. Park, and J. H. Roark. 1997. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15: 535-562.
3. Anfossi, N., V. Pascal, E. Vivier, and S. Ugolini. 2001. Biology of T memory type 1 cells. Immunol. Rev. 181: 269-278.
4. Phillips, J. H., J. E. Gumperz, P. Parham, and L. L. Lanier. 1995. Superantigen-dependent, cell-mediated cytotoxicity inhibited by MHC class I receptors on T lymphocytes. Science 268: 403-405.
5. van Bergen, J., A. Thompson, S. A. van der, T. H. Ottenhoff, J. Gussekloo, and F. Koning. 2004. Phenotypic and functional characterization of CD4 T cells expressing killer Ig-like receptors. J. Immunol. 173: 6719-6726.
6. Lafarge, X., V. Pitard, S. Ravet, D. Roumanes, F. Halary, C. Dromer, E. Vivier, P. Paul, J. F. Moreau, and J. Dechanet-Merville. 2005. Expression of MHC class I receptors confers functional intraclonal heterogeneity to a reactive expansion of γδ T cells. Eur. J. Immunol. 35: 1896-1905.
7. De Libero, G. 1999. Control of γδ T cells by NK receptors. Microbes. Infect. 1: 263-267.
8. Mingari, M. C., M. Ponte, C. Cantoni, C. Vitale, F. Schiavetti, S. Bertone, R. Bellomo, A. T. Cappai, and R. Biassoni. 1997. HLA-class I-specific inhibitory receptors in human cytolytic T lymphocytes: molecular characterization, distribution in lymphoid tissues and co-expression by individual T cells. Int. Immunol. 9: 485-491.
9. Uhrberg, M., N. M. Valiante, N. T. Young, L. L. Lanier, J. H. Phillips, and P. Parham. 2001. The repertoire of killer cell Ig-like receptor and CD94: NKG2A receptors in T cells: clones sharing identical αβ TCR rearrangement express highly diverse killer cell Ig-like receptor patterns. J. Immunol. 166: 3923-3932.
10. Vely, F., M. Peyrat, C. Couedel, J. Morcet, F. Halary, F. Davodeau, F. Romagne, E. Scotet, X. Saulquin, E. Houssaint, et al. 2001. Regulation of inhibitory and activating killer-cell Ig-like receptor expression occurs in T cells after termination of TCR rearrangements. J. Immunol. 166: 2487-2494.
11. null T cells. J. Immunol. 168: 3839-3846.
12. + T cells. J. Immunol. 173: 7223-7229.
13. + T lymphocyte subsets that express HLA class I-specific inhibitory receptors represent oligoclonally or monoclonally expanded cell populations. Proc. Natl. Acad. Sci. USA 93: 12433-12438.
14. Gumperz, J. E., N. M. Valiante, P. Parham, L. L. Lanier, and D. Tyan. 1996. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibility complex haplotype. J. Exp. Med. 183: 1817-1827.
15. Vivier, E., and N. Anfossi. 2004. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat. Rev. Immunol. 4: 190-198.
16. Speiser, D. E., D. Valmori, D. Rimoldi, M. J. Pittet, D. Lienard, V. Cerundolo, H. R. MacDonald, J. C. Cerottini, and P. Romero. 1999. CD28-negative cytolytic effector T cells frequently express NK receptors and are present at variable proportions in circulating lymphocytes from healthy donors and melanoma patients. Eur. J. Immunol. 29: 1990-1999.
17. Cook, M., D. Briggs, C. Craddock, P. Mahendra, D. Milligan, C. Fegan, P. Darbyshire, S. Lawson, E. Boxall, and P. Moss. 2006. Donor KIR genotype has a major influence on the rate of cytomegalovirus reactivation following T-cell replete stem cell transplantation. Blood 107: 1230-1232.
18. + T-cell-depleted allogeneic bone marrow transplantation. Transplantation 74: 49-54.
19. D'Andrea, A., C. Chang, J. H. Phillips, and L. L. Lanier. 1996. Regulation of T cell lymphokine production by killer cell inhibitory receptor recognition of self HLA class I alleles. J. Exp. Med. 184: 789-794.
20. Gati, A., N. Guerra, C. Gaudin, S. Da Rocha, B. Escudier, Y. Lecluse, A. Bettaieb, S. Chouaib, and A. Caignard. 2003. CD158 receptor controls cytotoxic T-lymphocyte susceptibility to tumor-mediated activation-induced cell death by interfering with Fas signaling. Cancer Res. 63: 7475-7482.
21. Henel, G., K. Singh, D. Cui, S. Pryshchep, W. W. Lee, C. M. Weyand, and J. J. Goronzy. 2006. Uncoupling of T-cell effector functions by inhibitory killer immunoglobulin-like receptors. Blood 107: 4449-4457.
22. Ikeda, H., B. Lethe, F. Lehmann, N. van Baren, J. F. Baurain, C. de Smet, H. Chambost, M. Vitale, A. Moretta, T. Boon, and P. G. Coulie. 1997. Characterization of an antigen that is recognized on a melanoma showing partial HLA loss by CTL expressing an NK inhibitory receptor. Immunity 6: 199-208.
23. Bakker, A. B., J. H. Phillips, C. G. Figdor, and L. L. Lanier. 1998. Killer cell inhibitory receptors for MHC class I molecules regulate lysis of melanoma cells mediated by NK cells, γδ T cells, and antigen-specific CTL. J. Immunol. 160: 5239-5245.
24. Guerra, N., M. Guillard, E. Angevin, H. Echchakir, B. Escudier, A. Moretta, S. Chouaib, and A. Caignard. 2000. Killer inhibitory receptor (CD158b) modulates the lytic activity of tumor-specific T lymphocytes infiltrating renal cell carcinomas. Blood 95: 2883-2889.
25. Guerra, N., F. Michel, A. Gati, C. Gaudin, Z. Mishal, B. Escudier, O. Acuto, S. Chouaib, and A. Caignard. 2002. Engagement of the inhibitory receptor CD158a interrupts TCR signaling, preventing dynamic membrane reorganization in CTL/tumor cell interaction. Blood 100: 2874-2881.
26. Young, N. T., M. Uhrberg, J. H. Phillips, L. L. Lanier, and P. Parham. 2001. Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL. J. Immunol. 166: 3933-3941.
27. + T cells. Nat. Immunol. 2: 430-435.
28. Chwae, Y. J., M. J. Chang, S. M. Park, H. Yoon, H. J. Park, S. J. Kim, and J. Kim. 2002. Molecular mechanism of the activation-induced cell death inhibition mediated by a p70 inhibitory killer cell Ig-like receptor in Jurkat T cells. J. Immunol. 169: 3726-3735.
29. + effector T cells and limits their proliferative capacity. Eur. J. Immunol. 34: 3413-3422.
30. Warren, H. S., P. M. Rana, D. T. Rieger, K. A. Hewitt, J. E. Dahlstrom, and A. L. Kent. 2006. CD8 T cells expressing killer Ig-like receptors and NKG2A are present in cord blood and express a more naive phenotype than their counterparts in adult blood. J. Leukocyte Biol. 79: 1252-1259.
31. Burrows, S. R., N. Kienzle, A. Winterhalter, M. Bharadwaj, J. D. Altman, and A. Brooks. 2000. Peptide-MHC class I tetrameric complexes display exquisite ligand specificity. J. Immunol. 165: 6229-6234.
32. Carr, W. H., D. B. Rosen, H. Arase, D. F. Nixon, J. Michaelsson, and L. L. Lanier. 2007. Cutting edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J. Immunol. 178: 647-651.
33. + T cells with helper activity as well as cytotoxic capacity. Gene Ther. 12: 1686-1695.
34. Colonna, M., G. Borsellino, M. Falco, G. B. Ferrara, and J. L. Strominger. 1993. HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. Proc. Natl. Acad. Sci. USA 90: 12000-12004.
35. Litwin, V., J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier. 1994. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules. J. Exp. Med. 180: 537-543.
36. Heemskerk, M. H., M. Hoogeboom, R. A. de Paus, M. G. Kester, M. A. van der Hoorn, E. Goulmy, R. Willemze, and J. H. Falkenburg. 2003. Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved α joining region. Blood 102: 3530 -3540.
37. Burk, M. R., L. Mori, and G. De Libero. 1995. Human Vγ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur. J. Immunol. 25: 2052-2058.
38. +-restricted phenotypes of human hematopoietic progenitor cells by retrovirus-mediated gene transfer. Hum. Gene Ther. 8: 1611-1623.
39. 2- microglobulin-deficient mice. Proc. Natl. Acad. Sci. USA 89: 653-657.
40. Heemskerk, M. H., B. Blom, G. Nolan, A. P. Stegmann, A. Q. Bakker, K. Weijer, P. C. Res, and H. Spits. 1997. Inhibition of T cell and promotion of natural killer cell development by the dominant negative helix loop helix factor Id3. J. Exp. Med. 186: 1597-1602.
41. Raulet, D. H., R. E. Vance, and C. W. McMahon. 2001. Regulation of the natural killer cell receptor repertoire. Annu. Rev. Immunol. 19: 291-330.
42. Heemskerk, M. H., R. S. Hagedoorn, M. A. van der Hoorn, L. T. van der Veken, M. Hoogeboom, M. G. Kester, R. Willemze, and J. H. Falkenburg. 2007. Efficiency of T-cell receptor expression in dual-specific T cells is controlled by the intrinsic qualities of the TCR chains within the TCR-CD3 complex. Blood 109: 235-243.